These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 8126147

  • 21. Effects on insulin secretion and insulin action of a 48-h reduction of plasma free fatty acids with acipimox in nondiabetic subjects genetically predisposed to type 2 diabetes.
    Cusi K, Kashyap S, Gastaldelli A, Bajaj M, Cersosimo E.
    Am J Physiol Endocrinol Metab; 2007 Jun; 292(6):E1775-81. PubMed ID: 17299078
    [Abstract] [Full Text] [Related]

  • 22. Acipimox increases glucose disposal in normal man independent of changes in plasma nonesterified fatty acid concentration and whole-body lipid oxidation rate.
    Fulcher GR, Walker M, Farrer M, Johnson AS, Alberti KG.
    Metabolism; 1993 Mar; 42(3):308-14. PubMed ID: 8487648
    [Abstract] [Full Text] [Related]

  • 23. Effect of gemfibrozil treatment in sulfonylurea-treated patients with noninsulin-dependent diabetes mellitus.
    Shen DC, Fuh MM, Shieh SM, Chen YD, Reaven GM.
    J Clin Endocrinol Metab; 1991 Sep; 73(3):503-10. PubMed ID: 1874929
    [Abstract] [Full Text] [Related]

  • 24. Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects.
    DeFronzo RA, Barzilai N, Simonson DC.
    J Clin Endocrinol Metab; 1991 Dec; 73(6):1294-301. PubMed ID: 1955512
    [Abstract] [Full Text] [Related]

  • 25. The effects of changes in plasma nonesterified fatty acid levels on oxidative metabolism during moderate exercise in patients with non-insulin-dependent diabetes mellitus.
    Akanji AO, Osifo E, Kirk M, Hockaday TD.
    Metabolism; 1993 Apr; 42(4):426-34. PubMed ID: 8487664
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. The effect of long-term pharmacological antilipolysis on substrate metabolism in growth hormone (GH)-substituted GH-deficient adults.
    Nielsen S, Møller N, Pedersen SB, Christiansen JS, Jørgensen JO.
    J Clin Endocrinol Metab; 2002 Jul; 87(7):3274-8. PubMed ID: 12107236
    [Abstract] [Full Text] [Related]

  • 28. Inhibition of lipolysis during acute GH exposure increases insulin sensitivity in previously untreated GH-deficient adults.
    Segerlantz M, Bramnert M, Manhem P, Laurila E, Groop LC.
    Eur J Endocrinol; 2003 Dec; 149(6):511-9. PubMed ID: 14640991
    [Abstract] [Full Text] [Related]

  • 29. Benfluorex in obese noninsulin dependent diabetes mellitus patients poorly controlled by insulin: a double blind study versus placebo.
    Pontiroli AE, Pacchioni M, Piatti PM, Cassisa C, Camisasca R, Pozza G.
    J Clin Endocrinol Metab; 1996 Oct; 81(10):3727-32. PubMed ID: 8855830
    [Abstract] [Full Text] [Related]

  • 30. Acute metabolic and hormonal responses to the inhibition of lipolysis in non-obese patients with non-insulin-dependent (type 2) diabetes mellitus: effects of acipimox.
    Fulcher GR, Walker M, Catalano C, Farrer M, Alberti KG.
    Clin Sci (Lond); 1992 May; 82(5):565-71. PubMed ID: 1317767
    [Abstract] [Full Text] [Related]

  • 31. The role of plasma non-esterified fatty acids during exercise in type 2 diabetes mellitus.
    Berrish TS, Elliott C, Cooper BG, Reed JW, Orskov H, Alberti KG, Walker M.
    Diabet Med; 1993 Mar; 10(2):152-8. PubMed ID: 8458192
    [Abstract] [Full Text] [Related]

  • 32. Inhibition of lipolysis improves insulin sensitivity in protease inhibitor-treated HIV-infected men with fat redistribution.
    Hadigan C, Rabe J, Meininger G, Aliabadi N, Breu J, Grinspoon S.
    Am J Clin Nutr; 2003 Feb; 77(2):490-4. PubMed ID: 12540412
    [Abstract] [Full Text] [Related]

  • 33. Sustained reduction in plasma free fatty acid concentration improves insulin action without altering plasma adipocytokine levels in subjects with strong family history of type 2 diabetes.
    Bajaj M, Suraamornkul S, Kashyap S, Cusi K, Mandarino L, DeFronzo RA.
    J Clin Endocrinol Metab; 2004 Sep; 89(9):4649-55. PubMed ID: 15356076
    [Abstract] [Full Text] [Related]

  • 34. Effects of insulin and acipimox on VLDL1 and VLDL2 apolipoprotein B production in normal subjects.
    Malmström R, Packard CJ, Caslake M, Bedford D, Stewart P, Yki-Järvinen H, Shepherd J, Taskinen MR.
    Diabetes; 1998 May; 47(5):779-87. PubMed ID: 9588450
    [Abstract] [Full Text] [Related]

  • 35. The reduction in postprandial lipemia after exercise is independent of the relative contributions of fat and carbohydrate to energy metabolism during exercise.
    Malkova D, Hardman AE, Bowness RJ, Macdonald IA.
    Metabolism; 1999 Feb; 48(2):245-51. PubMed ID: 10024090
    [Abstract] [Full Text] [Related]

  • 36. Effect of exenatide on 24-hour blood glucose profile compared with placebo in patients with type 2 diabetes: a randomized, double-blind, two-arm, parallel-group, placebo-controlled, 2-week study.
    Schwartz SL, Ratner RE, Kim DD, Qu Y, Fechner LL, Lenox SM, Holcombe JH.
    Clin Ther; 2008 May; 30(5):858-67. PubMed ID: 18555933
    [Abstract] [Full Text] [Related]

  • 37. Effect of acute inhibition of lipolysis on operation of the glucose-fatty acid cycle in hepatic cirrhosis.
    Farrer M, Fulcher GR, Johnson AJ, Record CO, Alberti KG.
    Metabolism; 1992 May; 41(5):465-70. PubMed ID: 1588824
    [Abstract] [Full Text] [Related]

  • 38. Beta cell response to oral glimepiride administration during and following a hyperglycaemic clamp in NIDDM patients.
    van der Wal PS, Draeger KE, van Iperen AM, Martini C, Aarsen M, Heine RJ.
    Diabet Med; 1997 Jul; 14(7):556-63. PubMed ID: 9223393
    [Abstract] [Full Text] [Related]

  • 39. Disproportionately elevated proinsulin levels reflect the degree of impaired B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus.
    Røder ME, Porte D, Schwartz RS, Kahn SE.
    J Clin Endocrinol Metab; 1998 Feb; 83(2):604-8. PubMed ID: 9467581
    [Abstract] [Full Text] [Related]

  • 40. Long-term effects of fish oil on insulin resistance and plasma lipoproteins in NIDDM patients with hypertriglyceridemia.
    Rivellese AA, Maffettone A, Iovine C, Di Marino L, Annuzzi G, Mancini M, Riccardi G.
    Diabetes Care; 1996 Nov; 19(11):1207-13. PubMed ID: 8908381
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.